-

Compelling Clinical Data Released for Carlsmed’s aprevo® Technology

CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed announced today that new clinical data on its aprevo® technology has been published in the Global Spine Journal. This landmark study of a patient-matched cohort concluded that the use of aprevo® personalized interbody devices enables a significant improvement in achieving alignment. The study measured the difference in pelvic incidence (PI) and lumbar lordosis (LL), referred to as PI-LL mismatch, comparing personalized spine surgery and traditional spine surgery. Prior studies have shown that achieving optimal alignment during spine fusion surgery is highly correlated with reduced complications.

Justin Smith, MD, PhD, the lead author, said, “In the publication, data is provided indicating that utilization of aprevo® patient-specific devices resulted in a 42% improvement in achieving PI-LL mismatch within 5° of the surgeons’ pre-operative plans.” The publication, Analysis of Personalized Interbody Implants in the Surgical Treatment of Adult Spinal Deformity, is available at https://journals.sagepub.com/doi/10.1177/21925682231216926.

“The mounting clinical evidence supports that AI-enabled personalized surgery improves outcomes and is transforming the standard of care for millions of patients in need,” said Mike Cordonnier, CEO of Carlsmed. “We will continue to advance the mission of personalization of healthcare and build awareness of the availability of this technology to patients worldwide.”

About Carlsmed

Carlsmed’s mission is to improve outcomes and decrease the cost of healthcare for spine surgery. The Carlsmed aprevo® personalized surgery platform is designed to improve the standard of care for spine surgery, one patient at a time. Carlsmed’s implantable devices and software platforms are FDA-cleared for lumbar spine fusion. Carlsmed’s proprietary digital production system enables the design and production of custom-made, anatomically designed aprevo® devices to be created on demand and delivered sterile packed to the hospital in time for surgery.

Contacts

For press and media inquiries, please contact Jodi Allen at jodi@carlsmed.com

Carlsmed


Release Versions

Contacts

For press and media inquiries, please contact Jodi Allen at jodi@carlsmed.com

Social Media Profiles
More News From Carlsmed

Carlsmed Announces FDA Clearance for aprevo® Cervical Breakthrough Fusion Device

CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed, Inc. (“Carlsmed” or the “Company”) a MedTech company pioneering AI-enabled personalized spine surgery, today announced FDA 510(k) clearance for the aprevo® Cervical ACDF Interbody System. This milestone underscores Carlsmed’s commitment to advancing patient-specific spine surgery solutions that enhance outcomes and surgical precision. The FDA previously granted Breakthrough Device designation for Carlsmed’s aprevo® technology for the treatment of pat...

Carlsmed Launches Cutting-Edge Digital Production Line, Revolutionizing Spine Surgery

CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed, a commercial-stage medical technology company and pioneer of the personalized spine surgery market, today announced the successful launch of its state-of-the-art digital production line. This innovative technology will enable the company to deliver its aprevo® personalized spinal fusion implants to hospitals in less than ten days. “This advancement is more than just a technical achievement,” said Mike Cordonnier, Chairman and CEO of Carlsmed. “The re...

Carlsmed Adds Industry Veteran, Kevin O’Boyle, to Board of Directors

CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed, the leader in personalized spine surgery, announced that Kevin O’Boyle has joined its Board of Directors and will serve as the Chair of the Audit Committee. Mr. O’Boyle previously served as a director of seven publicly traded companies, including Wright Medical Group (WMGI), GenMark Diagnostics (GNMK) and Zeltiq (ZLTQ). In addition to Carlsmed, he currently serves on the board of Nevro (NVRO). Mr. O’Boyle has over 20 years of executive management exp...
Back to Newsroom